Vaccines for Immune Mediated Diseases

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis B, Influenza and Pneumococcal vaccination.

 

    Related Conference of Vaccines for Immune Mediated Diseases

    November 08-09, 2021

    International Conference on Immunology Research

    Las Vegas, USA
    December 17-18, 2021

    11th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa
    December 20-21, 2021

    9th World Summit on Immunology & Immunotherapy

    Prague, Czech Republic
    December 23-23, 2021

    13th Annual Conference on Clinical Immunology

    Cape Town, South Africa
    December 23-23, 2021

    3rd International Conference on Viral Infection and Immune Response

    Amsterdam, Netherlands
    February 07-08, 2022

    International Conference on Vaccine Research

    Paris, France
    March 21-22, 2022

    37th International Conference on Immunology

    Brussels, Aland Islands
    March 21-22, 2022

    15th Global Summit on Immunology and Cell Biology

    Tokyo, Japan
    May 02-03, 2022

    16th International Conference on European Immunology

    Zurich, Switzerland

    Vaccines for Immune Mediated Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in